2026 Alzheimer’s Update
For more than a century Alzheimer’s disease has been thought to be incurable. But a recent study published in the New England Journal of Medicine (NEJM), and reported on by…
Continue Reading
2026 Alzheimer’s Update
UAE Launches First Genomics-Led Trial Aimed at Preventing Alzheimer’s Disease
As reported on PharmaTimes, the United Arab Emirates has taken a significant step toward preventive neurology with the initiation of its first clinical trial guided by population-scale genomics. Spearheaded by…
Continue Reading
UAE Launches First Genomics-Led Trial Aimed at Preventing Alzheimer’s Disease
New Trial Shows Diabetes Drug and Nasal Insulin May Boost Brain Health in Early Alzheimer’s
A Wake Forest University School of Medicine study reports that two existing medications (empagliflozin (Jardiance), a diabetes drug, and intranasal insulin) could improve brain health in individuals with mild cognitive…
Continue Reading
New Trial Shows Diabetes Drug and Nasal Insulin May Boost Brain Health in Early Alzheimer’s
Study Links Age to Increased Alzheimer’s-Related Brain Changes in Parkinson’s Patients Without Dementia
A new study published in Aging-US reveals that Parkinson’s disease (PD) patients diagnosed in their 80s are significantly more likely to exhibit amyloid-beta buildup, which is an early marker of…
Continue Reading
Study Links Age to Increased Alzheimer’s-Related Brain Changes in Parkinson’s Patients Without Dementia
Does Vitamin D Deficiency Have an Impact on Alzheimer’s Disease?
In a recent study, deficiency in Vitamin D was associated with an elevated risk of developing Alzheimer’s disease. Yet there were no indications that it is the direct cause of…
Continue Reading
Does Vitamin D Deficiency Have an Impact on Alzheimer’s Disease?
The FDA Now Requires Increased MRI Monitoring for Alzheimer’s Patients Who Are Treated with Leqembi
After the death of six patients, the FDA has announced that it will require earlier and more frequent monitoring of the monoclonal antibody Leqembi, the brand name for the Alzheimer’s…
Continue Reading
The FDA Now Requires Increased MRI Monitoring for Alzheimer’s Patients Who Are Treated with Leqembi
Denmark Researchers Have Created a Light-Based Technology That Improves Cognitive Function for Alzheimer’s Patients
Researchers at UC Berkeley, DTU, and OptoCeutics in Denmark have created a non-medical light-based technology that improved cognitive function for Alzheimer’s patients who have participated in previous clinical trials. The…
Continue Reading
Denmark Researchers Have Created a Light-Based Technology That Improves Cognitive Function for Alzheimer’s Patients
The FDA Has Approved Blood Testing for Alzheimer’s Disease
This week, the FDA approved the first blood-based diagnostic test for Alzheimer's disease (AD). The test, known as "Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio," is designed to detect amyloid…
Continue Reading
The FDA Has Approved Blood Testing for Alzheimer’s Disease
Never Give Up: Closing in on Alzheimer’s Disease
Immune dysfunction and inflammation have been found to play significant roles in Alzheimer's disease. An analysis of brain tissue in an animal model reveals a potential for immune system dysfunction at…
Continue Reading
Never Give Up: Closing in on Alzheimer’s Disease
Kapa65 / Pixabay
Alzheimer’s: Researchers at Japan’s Riken Center Discover a New Treatment to Alleviate Symptoms and Improve Memory
The Riken Center team, headed by Dr. Takaomi Saido and using mice with Alzheimer’s, discovered that dopamine may lessen the brain’s physical symptoms and improve memory. The study, featured in…
Continue Reading
Alzheimer’s: Researchers at Japan’s Riken Center Discover a New Treatment to Alleviate Symptoms and Improve Memory
source: shutterstock.com
Even as a Nurse, I Wasn’t Prepared for Life with Early Alzheimer’s Disease
Written by Linda Shows Let me start with, I’m BLESSED even though I have Alzheimer’s disease (AD). I am a blessed wife, mother, daughter, sister, friend, dog mom, nurse and…
Continue Reading
Even as a Nurse, I Wasn’t Prepared for Life with Early Alzheimer’s Disease
source: pixabay.com
His Alzheimer’s at 19 Continues to be a Mystery
In 2023 a 19-year-old male teenager was suffering from memory decline that first began when he was 17 years of age. His cognitive losses continued during the next few years.…
Continue Reading
His Alzheimer’s at 19 Continues to be a Mystery
source: shutterstock.com
When Might You Consider Genetic Testing for Alzheimer’s Disease?
This article was written by and shared with permission from Shannon Wieloch, MS. Shannon is a certified genetic counselor and patient advocate for the Aicardi-Goutiere Syndrome Advocacy Association and founder of Stork Genetics.…
Continue Reading
When Might You Consider Genetic Testing for Alzheimer’s Disease?
source: shutterstock.com
Blood Tests May be the Future for Early Alzheimer’s Detection
It is estimated that over six million people in the U.S. have Alzheimer’s disease plus millions of other people throughout the world. Alzheimer’s is the most common type of dementia.…
Continue Reading
Blood Tests May be the Future for Early Alzheimer’s Detection
source: shutterstock.com
Japanese Scientists Reversed Signs of Alzheimer’s by Restoring Synapse Function in Mouse Model
A team of scientists from Japan appear to have pioneered a method for reversing synapse damage in an Alzheimer's disease mouse model. Although encouraging, the theory must be tested in…
Continue Reading
Japanese Scientists Reversed Signs of Alzheimer’s by Restoring Synapse Function in Mouse Model
source: shutterstock.com
FDA’s Panel of Experts Vote 11-0 in Favor of Donanemab to Treat Alzheimer’s Disease
The idiom ‘third time’s a charm’ may have some significance in this instance. The panel that advises the FDA just voted unanimously in favor of Eli Lilly’s experimental drug, donanemab.…
Continue Reading
FDA’s Panel of Experts Vote 11-0 in Favor of Donanemab to Treat Alzheimer’s Disease
kkolosov / Pixabay
Encouraging Results from a Phase 2 Study of IL-2 to Treat Alzheimer’s Patients
BioSpace recently published a press release discussing the interim results highlighting a Coya Therapeutics’ study. The study evaluates the safety, tolerability, and biological activity of LD IL-2 in 38 patients…
Continue Reading
Encouraging Results from a Phase 2 Study of IL-2 to Treat Alzheimer’s Patients
source: pixabay.com
Study of the Week: Brain Acidity Linked to a Wide Range of Neurological Diseases
Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…
Continue Reading
Study of the Week: Brain Acidity Linked to a Wide Range of Neurological Diseases
source: shutterstock.com
FDA Puts Off Decision on Approval of a New Alzheimer’s Treatment
During the past three years two drugs (Aduhelm and Leqembi) that were designed to slow the progression of Alzheimer’s disease, have been approved. A verdict by the FDA on a…
Continue Reading
FDA Puts Off Decision on Approval of a New Alzheimer’s Treatment
source: shutterstock.com
Study Lists Neurological Disease as the Top Cause of Disability and Illness Around the World
Neurological conditions now have the highest rates of disability and ill health worldwide. The Disparity Although more than 80% of the neurological deaths and nervous system disorders occur in lower…
Continue Reading
Study Lists Neurological Disease as the Top Cause of Disability and Illness Around the World
source: shutterstock.com
Alzheimer’s: Researchers Leave No Stone Unturned
Researchers have demonstrated renewed interest in vaccines that treat Alzheimer’s. The treatments remove toxic proteins from the brain. The author of a recent article in Reuters interviewed ten researchers and…
Continue Reading
Alzheimer’s: Researchers Leave No Stone Unturned
source: shutterstock.com
Does Brain Inflammation Play a Role in Alzheimer’s Disease?
Neurogeneticist Michael Nalls of the US National Institute on Aging recently told Science Alert that a 2022 study, published in the Journal of Alzheimer’s Disease, completely changed their discovery approach.…
Continue Reading
Does Brain Inflammation Play a Role in Alzheimer’s Disease?
source: pixabay.com
Alzheimer’s: A Neuroscientist at the OHSU Claims Scientists Missed a Major Form of Cell Death
Ferroptosis, a form of cell death, destroys microglia cells, which are associated with the brain’s immune system in vascular dementia and Alzheimer’s. Dr. Stephen Back suggested that attention had not…
Continue Reading
Alzheimer’s: A Neuroscientist at the OHSU Claims Scientists Missed a Major Form of Cell Death
PublicDomainPictures / Pixabay
Using Fruit Flies, Researchers Find Potential Genetic Link to Alzheimer’s
Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…
Continue Reading
Using Fruit Flies, Researchers Find Potential Genetic Link to Alzheimer’s
source: shutterstock.com
Alzheimer’s: Another Drug Failure Has the Researchers Questioning the Science
Roche has added another failure this year with its drug gantenerumab. As noted in Fierce Biotech, the drug was unable to improve functional or cognitive decline in two Phase…
Continue Reading
Alzheimer’s: Another Drug Failure Has the Researchers Questioning the Science
